4-69096892-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP7BA1
The NM_001074.4(UGT2B7):āc.372A>Gā(p.Arg124=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.166 in 1,611,946 control chromosomes in the GnomAD database, including 23,270 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as drug response (no stars).
Frequency
Genomes: š 0.15 ( 1877 hom., cov: 32)
Exomes š: 0.17 ( 21393 hom. )
Consequence
UGT2B7
NM_001074.4 synonymous
NM_001074.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0270
Genes affected
UGT2B7 (HGNC:12554): (UDP glucuronosyltransferase family 2 member B7) The protein encoded by this gene belongs to the UDP-glycosyltransferase (UGT) family. UGTs serve a major role in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. This protein is localized in the microsome membrane, and has unique specificity for 3,4-catechol estrogens and estriol, suggesting that it may play an important role in regulating the level and activity of these potent estrogen metabolites. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP7
Synonymous conserved (PhyloP=-0.027 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.171 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
UGT2B7 | NM_001074.4 | c.372A>G | p.Arg124= | synonymous_variant | 1/6 | ENST00000305231.12 | |
UGT2B7 | NM_001330719.2 | c.372A>G | p.Arg124= | synonymous_variant | 1/5 | ||
UGT2B7 | NM_001349568.2 | c.-26-1648A>G | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
UGT2B7 | ENST00000305231.12 | c.372A>G | p.Arg124= | synonymous_variant | 1/6 | 1 | NM_001074.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.148 AC: 22423AN: 152016Hom.: 1876 Cov.: 32
GnomAD3 genomes
AF:
AC:
22423
AN:
152016
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.158 AC: 39244AN: 248336Hom.: 3426 AF XY: 0.163 AC XY: 21880AN XY: 134540
GnomAD3 exomes
AF:
AC:
39244
AN:
248336
Hom.:
AF XY:
AC XY:
21880
AN XY:
134540
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.168 AC: 245478AN: 1459812Hom.: 21393 Cov.: 32 AF XY: 0.169 AC XY: 122583AN XY: 726152
GnomAD4 exome
AF:
AC:
245478
AN:
1459812
Hom.:
Cov.:
32
AF XY:
AC XY:
122583
AN XY:
726152
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.147 AC: 22436AN: 152134Hom.: 1877 Cov.: 32 AF XY: 0.147 AC XY: 10905AN XY: 74378
GnomAD4 genome
AF:
AC:
22436
AN:
152134
Hom.:
Cov.:
32
AF XY:
AC XY:
10905
AN XY:
74378
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
550
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: drug response
Submissions summary: Other:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Tramadol response Other:1
drug response, no assertion criteria provided | research | Bruce Budowle Laboratory, University of North Texas Health Science Center | Apr 28, 2018 | - T:M1 = postmortem ratio or tramadol to O-desmethyltramadol; t-MP = model-based clustered metabolizer phenotype inferred from T:M1 |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at